載入...
Development of Immunotherapy Combination Strategies in Cancer
Harnessing the immune system to treat cancer through inhibitors of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) and Programmed Death Ligand-1 (PD-L1) has revolutionalized the landscape of cancer. Rational combination strategies aim to enhance the antitumor effects of immunotherapies, but require a deep...
Na minha lista:
| 發表在: | Cancer Discov |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8178168/ https://ncbi.nlm.nih.gov/pubmed/33811048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-20-1209 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|